三维定向CT引导射频消融治疗膈顶部原发性肝癌的可行性

Feasibility of Three-Dimensional Directional CT Guided Radiofrequency Ablation for Primary Hepatocellular Carcinoma at the Top of Diaphragm

目的探讨三维定向CT引导射频消融应用于膈顶部原发性肝癌治疗的临床效果。方法选取2013年3月~2014年3月于本院诊治的原发性肝癌患者40例作为研究对象,其共有50个膈顶病灶,对所有膈顶病灶进行三维定向CT引导射频消融治疗(CT-RFA),观察并记录患者手术治疗的成功率、病灶完全消融率、术后并发症、复发情况以及安全性。结果所有患者经CT-RFA治疗后均有显著的临床疗效,经检查手术成功率为100%,完全消融率为94%,有8例患者术后出现并发症(20%),患者的中位局部无复发时间为(1778±232)个月。结论运用CT-PFA治疗膈顶部原发性肝癌可有效消融病灶,临床治疗效果显著,值得临床推广。

Objective To investigate the clinical effect of three dimensional directional CT guided radiofrequency ablation on primary hepatocellular carcinoma Method Forty cases of patients with hepatocellular carcinoma in our hospital from March2013to March2014were selected as the research object,with50focuses at the top of diaphragm CT guided radiofrequency ablation was performed on all diaphragmatic lesions The success rate,complete ablation rate,postoperative complications,recurrence and safety of the patients were observed and recorded Results All patients after CT guided radiofrequency ablation treatment have significant clinical efficacy The success rate of the operation was100%,and the total ablation rate was94%Postoperative complications occurred in8patients,and the median local recurrence time of the patient was(1778±232)months Conclusion Using CT guided radiofrequency ablation to treat primary hepatic carcinoma on the top of the diaphragm could effectively remove the lesion,and the clinical treatment effect was remarkable,which was worthy of clinical promotion